Go to content
UR Home

Neues zur symptomatischen MS‑Therapie: Teil 2 – Gangstörung und Spastik

Henze, T., Feneberg, W., Flachenecker, P., Seidel, D., Albrecht, H., Starck, M. and Meuth, S. G. (2017) Neues zur symptomatischen MS‑Therapie: Teil 2 – Gangstörung und Spastik. Der Nervenarzt 88 (12), pp. 1428-1434.

Full text not available from this repository.

at publisher (via DOI)

Other URL: http://doi.org/10.1007/s00115-017-0439-3


Abstract

The symptomatic treatment of multiple sclerosis (MS) nowadays is of similar importance as immunotherapy within a comprehensive concept of therapy of this chronic disease, since it contributes considerably to the reduction of disabilities in activities of daily living as well as social and occupational life. Moreover, symptomatic treatment is of great importance for amelioration of quality of ...

plus


Export bibliographical data



Item type:Article
Date:2017
Institutions:Medicine > Lehrstuhl für Neurologie
Identification Number:
ValueType
10.1007/s00115-017-0439-3DOI
Keywords:QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; OROMUCOSAL SPRAY; SAFETY; NABIXIMOLS; EXERCISE; EFFICACY; ADULTS; DALFAMPRIDINE; METAANALYSIS; Multiple sclerosis; Symptomatic therapy; Review; Gait disorder; Spasticity
Dewey Decimal Classification:600 Technology > 610 Medical sciences Medicine
Status:Published
Refereed:Yes, this version has been refereed
Created at the University of Regensburg:Yes
Item ID:39520
Owner only: item control page
  1. Homepage UR

University Library

Publication Server

Contact:

Publishing: oa@ur.de

Dissertations: dissertationen@ur.de

Research data: daten@ur.de

Contact persons